On Air Now

Tune in to Listen

99.9 FM Hibbing, MN

Weather

Current Conditions(Hibbing,MN 55746)

More Weather »
55° Feels Like: 55°
Wind: SSW 0 mph Past 24 hrs - Precip: 0.17”
Current Radar for Zip

Tonight

Partly Cloudy 51°

Tomorrow

PM Thunderstorms 76°

Thurs Night

Thunderstorms 60°

Alerts

  • 0 Severe Weather Alerts
  • 0 Cancellations

Reckitt Benckiser to develop XenoPort alcohol abuse drug

LONDON (Reuters) - Reckitt Benckiser Group's pharmaceuticals unit will develop and sell XenoPort Inc's drug to treat alcohol use disorders, the companies said on Thursday.

Under the terms of the exclusive global licensing deal, XenoPort is entitled to $20 million up front, followed by another $5 million upon the transfer of certain technology and materials and aggregate payments of up to $70 million upon Reckitt's achievement of development and regulatory milestones, and $50 million for commercial milestones.

(Reporting by Martinne Geller; Editing by Erica Billingham)

Comments